Gregory, A. P., C. A. Dendrou, K. E. Attfield, A. Haghikia, D. K. Xifara, F. Butter, G. Poschmann, G. Kaur, L. Lambert, O. A. Leach, S. Promel, D. Punwani, J. H. Felce, S. J. Davis, R. Gold, F. C. Nielsen, R. M. Siegel, M. Mann, J. I. Bell, G. McVean and L. Fugger: TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. In: Nature 488, 7412, 508-511 (2012).
Krumbholz, M., H. Pellkofer, R. Gold, L. A. Hoffmann, R. Hohlfeld and T. Kümpfel: Delayed allergic reaction to natalizumab associated with early formation of neutralizing antibodies.. In: Archives of Neurology 64, 1331-1333 (2007).
Gold, R. and C. Linington: Glatiramer acetate treatment in Devic's neuromyelitis optica - Reply. In: Brain 126, E1-E1 (2003).
Gold, R. and C. Linington: Devic's disease: bridging the gap between laboratory and clinic. In: Brain 125, 1425-1427 (2002).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.